Sebia is the global leader in cutting-edge clinical protein electrophoresis technology for in-vitro diagnostic (IVD) testing. Our protein analysis systems enable the screening and monitoring of various diseases and conditions, including oncology (Multiple Myeloma), metabolic disorders (Diabetes), an...See more
Headquarters:
Singapore
Company Type:
SME
Company size:
11-50 Employees
Year Founded:
2021 (5 years)
Address:
51 CHANGI BUSINESS PARK CENTRAL 2; #09-12, THE SIGNATURE; SINGAPORE, 486066, SG
The company has a sophisticated ownership structure and may be part of a large corporate group
The company's annual budgeting is likely to take place between October - December
LOW
spending power